CVE-2015-3965 Privilege escalation in Symbiq Infusion System
Remote authenticated users can escalate privileges to trigger unanticipated operations on Hospira Symbiq Infusion Systems.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2015-3965?
CVE-2015-3965 is a high-severity vulnerability in Hospira Symbiq Infusion System, published on 23 Mar 2019. Any signed-in user can exploit it over the network, with no action from the victim.
Official description
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Weakness: CWE-264
Which versions are affected by CVE-2015-3965?
It affects 1 product.
Products include Pfizer Symbiq Infusion System Firmware.
How do I fix CVE-2015-3965?
No fix has been published for CVE-2015-3965 yet. Limit exposure of the affected software until one is available.
Is CVE-2015-3965 being exploited?
There is no known exploitation of CVE-2015-3965 in the wild and no public exploit code.
Sources
Also known as GHSA-fw6x-q668-xp72.